Why Are Software Stocks Down?

Software stocks have underperformed to start 2026, with the iShares Expanded Tech-Software ETF down roughly 20% YTD as investors punish rising infrastructure spending and stretched valuations. Big tech hyperscalers (Microsoft, Alphabet, Amazon) have poured hundreds of billions into AI capex over the past three years and forecasts signal more than $500 billion in cumulative AI infrastructure spend, raising skepticism about ROI. Valuation pressure is acute for some AI-focused SaaS names—Palantir's forward price-to-sales is about double its nearest SaaS peer—while LLMs from Anthropic and OpenAI pose integration-driven disruption risks to traditional software; the author recommends selectively buying blue‑chip software leaders rather than speculative names.

Analysis

Market structure is bifurcating: GPU/AI-infrastructure suppliers (NVDA, select networking and power vendors) are the clear winners as hyperscalers push toward an incremental >$500B cumulative capex wave in 2026, tightening GPU supply and supporting >20%+ year-over-year revenue growth for dominant GPU vendors. Hyperscalers (MSFT, GOOGL, AMZN) bear near-term margin pressure as capex dilutes free cash flow, and high-multiple SaaS names (PLTR notably at ~2x the peer forward P/S) are vulnerable to violent de-rating if quarterly beats don’t meet sky-high expectations. Cross-asset: expect higher corporate bond issuance by some cloud builders, elevated equity implied volatility in software (option skew), stronger copper/electricity demand near term, and potential USD strength if investors reprice risk into safe-haven assets.

Tail risks include regulatory AI constraints (EU/US rules within 6–18 months), a GPU supply-chain shock, or a macro-driven enterprise IT freeze that contracts ARR by >10% across small-cap SaaS. Immediate (days) risks are sentiment-driven flow and earnings swings; short-term (weeks–months) hinge on hyperscaler capex guidance and SaaS quarterly prints; long-term (quarters–years) favors platform owners who integrate LLMs and capture incremental monetization. Hidden dependency: many SaaS businesses rely on hyperscaler marketplaces and could be disintermediated if LLMs become primary UX.

Trade implications: favor conviction longs in NVDA (dominant GPU share) and measured buys in blue-chip hyperscalers on >8–12% pullbacks; short or buy downside protection on overvalued AI-SaaS like PLTR ahead of key earnings. Use relative-value: long NVDA vs short iShares Expanded Tech-Software ETF (IGV) to express infra win/ SaaS pain. Options: buy 9–12 month NVDA LEAPs 20–30% OTM for asymmetric upside, and buy 3-month PLTR puts 25% OTM into earnings to limit capital at risk.

Contrarian view: the market may be over-penalizing durable hyperscalers—past large-scale infrastructure cycles (cloud 2013–2018) ultimately expanded monetization; NVDA upside may be underpriced while some small-cap SaaS fear is overdone. However, PLTR is binary: if it misses growth margins by >200bps, downside could be 30–50% fast. Watch two quantitative triggers to flip stance: (1) hyperscaler capex guidance change >±10% vs prior, and (2) sector-wide gross-margin compression >200bps over a quarter.

Key Decisions for Investors

• Establish a 2–4% portfolio long in NVDA via a mix of cash equity (50%) and 9–12 month LEAP calls (50%), targeting 20–30% OTM strikes to capture continued GPU pricing power; reassess after next NVDA earnings (within 6–8 weeks) if revenue beat >10% vs consensus.
• Reduce small-cap SaaS exposure by 4–6% and redeploy into MSFT and GOOGL: initiate 1–2% positions each on dips of ≥8% within the next 3 months or if forward P/E drops below 25, banking on durable platform monetization of LLM services.
• Take a tactical bearish stance on PLTR: initiate a 1–2% notional short or buy 3-month puts 25% OTM into the next earnings cycle (expect asymmetric downside of 30–50% if it misses); set a hard stop-loss at a 20% adverse move.
• Implement a pair trade: long NVDA vs short IGV (dollar-neutral, 1:1) sized at 1–2% net exposure to capture infra vs SaaS dispersion; rebalance monthly and close or reweight if NVDA outperforms by >25% or IGV underperforms by >25%.